LimV.S., FangV.S., KatzA., RefetoffS.: Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.J. Clin. Invest.,60, 522–534, 1977.
2.
ChopraI.J., SmithS.R.: Circulating thyroid hormones and thyrotropin in adult patients with protein-calorie malnutrition.J. Clin. Endocrinol. Metab.,40, 221–227, 1975.
3.
CarterJ.N., EastmanC.J., CorcoranJ.M., LazarusL.: Effect of severe chronic illness on thyroid function.Lancet2, 971–974, 1974.
4.
ChopraI.J., ChopraU., SmithS.R., RezaM., SolomonD.H.: Reciprocal changes in the serum concentration of 3,3,5′ triiodothyronine (reverse T3) and 3,3′,5 triiodothyronine (T3) in systemic illness.J. Clin. Endocrinol. Metab.,41, 1043–1049, 1975.
5.
BermudezF., SurksM.I., OppenheimerJ.H.: High incidence of decreased serum triiodothyronine concentrations in patients with nonthyroidal disease.J. Clin. Endocrinol. Metab.,41, 27–40, 1975.
6.
KapteinE.M., RobinsonW.J., GriebD.A., NicoloffJ.T.: Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses.J. Clin. Invest.,69, 526–535, 1982.
7.
ChopraI.J., TecoG.N.C., NyugenA.H., SolomonD.H.: In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroidal illnesses.J. Clin. Endocrinol. Metab.,49, 63–69, 1979.
Alvarez-UdeF., Gomez-PanA., EveredD.C., DuneA., HullR., KerD.N.S.: Pituitary response to thyrotropin releasing hormone in patients with chronic renal failure. Proc. 6th Int. Congr.Nephrol., p 883 (Abstract) 1975
10.
KalkW.J., MorkleyJ.E., GoldC.H., MeyersA.: Thyroid function tests in patients on regular hemodialysis.Nephron,25, 1173–178, 1980.
11.
CzernichowP., DauzetM.C., BroyenM., RapportR.: Abnormal TSH, PRL, GH response to TRH releasing factor in chronic renal failure.J. Clin. Endocrinol Metab.,43, 630–637, 1976.
12.
PikroyH., EpsteinS., HendricksS., PrimstoneB.: Thyrotropin response to intravenous thyrotropin releasing hormone in patients with hepatic and renal failure.Horm. Metab. Res.,6, 132, 1974.
13.
RamirezG., O'NeillW.Wm.Jr., JubizW., BloomerH.A.: Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities.Ann. Intern. Med.,84, 672–676, 1976.
14.
GudelskyG.H., PorterJ.C.: Release of dopamine from tuberoinfundibular neurons in pituitary stalk blood following prolactin and haloperidol administration.Endocrinology,106, 626–629, 1980.
15.
PorterJ.C., NanselD.D., GudelskyG.A., ForemanM.M., PilotteN.S., ParkerC.R.Jr., BurrowsG.H., BatesG.W., MaddenJ.D.: Neuroendocrine control of gonadotropin secretion.Fedn. Proc.,39, 2896–2901, 1980.
16.
ScanlonM.F., WeightmanD.R., ShaleD.J., MoraB., HeathM., SnowM.H., LewisM., HallR.: Dopamine is a physiological regulator of throtropin (TSH) secretion in normal man.Clin. Endocrinol.,10, 7–15, 1979.
17.
WeetmanA.P., WeightmanD.R., ScanlonM.F.: Impaired dopaminergic control of thyroid stimulating h-ormone secretion in chronic renal failure.Clin. Endocrinol.,15, 451–456, 1981.
18.
McCannS.M., VijayanE., Negro-VilarA.: The role of gamma aminobutyric acid in control of anterior pituitary hormone release.Adv. Biochem. Psychopharmac.,20, 237–246, 1980.
19.
EliasA.N., SzekeresA.V., StoneS.CV., WeathersbeeP., ValentaL.J., HawT.: GABAergic and dopaminergic reguplation of thyroid stimulating hormone secretion in man - effects of baclofen and metoclopramide.Horm. Res.,191, 171–175, 1984.
20.
EliasA.N., SzekeresA.V., StoneS.C., ValentaL.J., AscherM.: GABAergic and dopaminergic mechanisms in gonadotropin secretion in man - effects of baclofen and metoclopramide.Acta Endocrinol.,103, 451–456, 1983.
21.
GodinY., HeinerL., MarkJ., MandelP.: Effect of di-n-propylacetate, an anticonvulsant compound on GABA metabolism.J. Neurochem.,16, 869–873, 1969.
22.
EliasN., ValentaL.J., SzekeresA.V., GrossmanM.K.: Effect of di-n-propylacetic acid (valproic acid) on the TSH response to TRH - a presumptive role for gamma aminobutyric acid.Metabolism,30, 1021–1023, 1981.
23.
GrandisonL., GuidottiA.: γ-Aminobutyric acid receptor function in rat pituitary: evidence for control of prolactin release.Endocrinology,105, 754–759, 1979.
24.
GrandisonL., CavagniniR., SchmidC., InvittiC., GuidottiA.: γ-Aminobutyric acid and benzodiazepine binding sites in human anterior pituitary tissue.J. Clin. Endocrinol Metab.,54, 597–601, 1982.
25.
EmmanouelD.S., LindheimerM.D., KatzA.I.: Pathogenesis of endocrine abnormalities in uremia.Endocrine Review,1, 28–44, 1980.
26.
SpectorD.A., DavisP.J., HeldermanJ.H., BellB., UtigerR.D.: Thyroid function and metabolic state in chronic renal failure.Ann. Intern. Med.,85, 724–730, 1976.
27.
VaamondeC.A., MichaelV.F.: The kidney in thyroid dysfunction, in SukiW.N., EnkoyanG. (eds). The kidney in Systemic Diseasesed. 2, New York, Wiley Medical Publications, pp. 361–412, 1981.
28.
VaziriN.D., GwinupG., MartinD.C., SeltzerJ.: Thyroid function in end-stage renal failure after successful renal transplantation.Clin. Nephrol.,15, 131–134, 1981.
